- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07606157
Effects of Kinesiotaping in Osteoarthritis (Taping)
Effects of Adding Kinesiotaping to Conventional Physiotherapy on Pain, Function, and Kinesiophobia in Knee Osteoarthritis: A Randomized Controlled Trial
Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.
This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.
A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.
Studieoversikt
Detaljert beskrivelse
Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.
This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.
A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Nazli Assoc. Prof. Nazli Cigercioglu, Assoc. Prof.
- Telefonnummer: +90 541 290 32 93
- E-post: nazlicigercioglu@gmail.com
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Diagnosis of unilateral grade 2 knee osteoarthritis,
- Age between 40 and 65 years,
- Ability to understand and comply with assessments and interventions,
- Independent ambulation without assistive devices,
- No participation in a physiotherapy program for knee-related complaints within the previous year
Exclusion Criteria:
- History of lower extremity surgery or trauma,
- Presence of neurological or orthopedic conditions affecting gait or physical function,
- Allergic reaction to kinesiotape,
- Inability to walk independently.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Sekvensiell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Kinesiotaping
|
Kinesiotaping
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Kinesiophobia
Tidsramme: 4 weeks
|
Kinesiophobia will evaluated using the Tampa Scale of Kinesiophobia (TSK) and the Fear-Avoidance Beliefs Questionnaire (FABQ).
The TSK is a 17-item questionnaire scored on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), with total scores ranging from 17 to 68, where higher scores indicate greater fear of movement.
The FABQ assesses fear-avoidance beliefs related to physical activity and has been widely used in musculoskeletal disorders.
|
4 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain intensity
Tidsramme: 4 weeks
|
Pain intensity will be assessed using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from "no pain" (0) to "worst imaginable pain" .
Participants will be asked to indicate the intensity of their knee pain during activity, and the marked distance will be measured in centimeters
|
4 weeks
|
|
Functional status
Tidsramme: 4 weeks
|
Functional status will be assessed using performance-based tests.
The 30-Second Sit-to-Stand Test will be used to evaluate lower extremity muscle strength and endurance.
Participants will be instructed to stand up and sit down as many times as possible within 30 seconds, and the total number of repetitions will be recorded .
|
4 weeks
|
|
Functional mobility
Tidsramme: 4 weeks
|
The 12-Step Stair Climb Test will be used to assess functional mobility and lower limb performance.
Participants will be asked to ascend and descend a 12-step staircase as quickly and safely as possible, and the total time taken to complete the task will be recorded in seconds .
|
4 weeks
|
|
Dynamic balance
Tidsramme: 4 weeks
|
Dynamic balance will be evaluated using the Functional Reach Test.
Participants will be instructed to stand upright and reach forward as far as possible without losing balance or taking a step.
The maximum distance reached will be measured in centimeters .
|
4 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Cigercioglu, Hacettepe University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- OA_RCS_2026
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .